Sign in to continue:

Wednesday, April 1st, 2026

McCormick & Company Reports Strong Q1 2026 Performance and Reaffirms Full-Year Outlook

McCormick & Company Reports Strong Q1 2026 Results, Reaffirms Fiscal Outlook, and Consolidates McCormick de Mexico

Key Financial Highlights

  • Net Sales: Increased 16.7% year-over-year to \$1.87 billion, including a 3.1% favorable foreign currency impact. Organic sales growth was 1.2%.
  • Operating Income: Rose to \$228 million from \$225 million in the prior year. Adjusted operating income climbed 18.8% to \$268 million.
  • Earnings Per Share (EPS): Reported EPS was \$3.77, up from \$0.60 in Q1 2025, driven by a significant non-cash gain related to the McCormick de Mexico acquisition. Adjusted EPS was \$0.66, up from \$0.60.
  • Gross Profit: Increased 17.4% to \$708.9 million, with adjusted gross profit at \$723.9 million.
  • Gross Profit Margin: Improved to 37.8% (adjusted: 38.6%).
  • Cash Flow: Operating cash flow was \$50.9 million, reflecting acquisition-related outflows but a healthy underlying business.

Strategic and Operational Developments

  • Acquisition of McCormick de Mexico: The company acquired an additional 25% stake, bringing its total ownership to 75%. This resulted in a non-cash gain of \$866.8 million from remeasuring the previously held equity interest, which dramatically boosted reported net income and EPS. The consolidation of McCormick de Mexico’s results is expected to have a meaningful impact going forward.
  • Segment Performance:
    • Consumer Segment: Net sales up 24.5%, driven by robust Americas performance (+30.4%). Organic growth of 1.8%.
    • Flavor Solutions Segment: Net sales up 6.2%, with organic growth of 0.5%.
  • Margin Expansion: Adjusted operating income and margins improved due to acquisition accretion and disciplined cost management.
  • Currency Impact: Favorable FX contributed 3.1% to net sales growth and is expected to add 1% to sales, operating income, and EPS for the full year.

2026 Financial Outlook Reaffirmed

  • Net Sales Growth: 13% to 17% reported; 12% to 16% constant currency; organic sales growth expected between 1% and 3%.
  • Adjusted Operating Income: Growth of 16% to 20% reported, 15% to 19% constant currency.
  • Adjusted EPS: Guidance of \$3.05 to \$3.13, representing 2% to 5% growth (1% to 4% constant currency).
  • Acquisition Contribution: The McCormick de Mexico deal is expected to add 11% to 13% to net sales growth.
  • Profitability Outlook: Margin expansion is expected to be sustained, supported by the company’s CCI (Comprehensive Continuous Improvement) program and ongoing streamlining initiatives.
  • Cash Flow: Strong cash flow is projected, with a significant portion to be returned to shareholders via dividends.

CEO Commentary

Brendan M. Foley, Chairman, President, and CEO, highlighted the resilience of McCormick’s business, underscoring strong sales and margin expansion. Foley attributed the positive results to the McCormick de Mexico acquisition, organic growth, and disciplined cost management. He reaffirmed the company’s commitment to investing in innovation, brand strength, and distribution gains, expecting sequential volume improvement throughout the year. The CEO also expressed gratitude to McCormick’s global employees and emphasized the company’s focus on building a future-ready, growth-oriented organization.

Shareholder-Important and Potentially Price-Sensitive Factors

  • Major Acquisition Impact: The consolidation of McCormick de Mexico’s results is a transformative event, generating a one-time non-cash gain and significantly increasing the company’s asset base and non-controlling interest. This is price-sensitive and may affect future earnings comparability.
  • Strong Start to Fiscal Year: The company’s ability to deliver double-digit sales growth and margin expansion in Q1, along with reaffirmed guidance, supports positive investor sentiment and may drive share price momentum.
  • Reaffirmed Guidance: Maintaining full-year growth targets despite macro uncertainties (including global trade and Middle East conflict) signals management confidence and operational robustness.
  • Cash Flow and Dividends: Commitment to strong cash flow and shareholder returns through dividends remains intact.
  • Non-GAAP Adjustments: Investors should note the large gap between reported and adjusted EPS due to acquisition-related accounting, which may affect perceptions of underlying performance.

Risks and Forward-Looking Statements

The report notes potential risks, including macroeconomic conditions, global conflicts, inflation, supply chain dynamics, foreign currency fluctuations, and the integration of acquisitions. The company is unable to precisely forecast special charges or integration costs for the remainder of 2026, which could impact reported results. Management also highlights the ongoing importance of productivity initiatives and innovation investments in sustaining future growth.

Financial Tables (Summary)

  • Q1 2026 Consolidated Income Statement:
    • Net sales: \$1,873.9 million
    • Operating income: \$227.5 million
    • Net income attributable to McCormick: \$1,016.2 million (boosted by \$866.8 million gain)
    • Diluted EPS: \$3.77 (adjusted: \$0.66)
  • Balance Sheet as of February 28, 2026:
    • Total assets: \$16,346.3 million (up from \$13,200.4 million at November 30, 2025)
    • Total shareholders’ equity: \$7,556.1 million (up from \$5,768.1 million)
    • Cash and equivalents: \$177.7 million
  • Cash Flow Statement (Three Months):
    • Net cash from operations: \$50.9 million
    • Net cash used in investing: \$(762.4) million (reflecting the acquisition)
    • Net cash from financing: \$781.7 million
    • Ending cash: \$177.7 million

Conclusion

McCormick & Company’s Q1 2026 report contains several material developments that could drive share price movement. The successful consolidation of McCormick de Mexico is a game-changer, boosting near-term reported profits and enhancing the company’s growth platform in Latin America. Strong operating and adjusted results, margin expansion, and robust guidance reaffirm management’s confidence in the face of ongoing macroeconomic and geopolitical headwinds. Investors should carefully consider both the reported and adjusted figures—particularly the one-time gain—and monitor ongoing integration progress and volume trends as the year progresses.


Disclaimer: This summary is for informational purposes only and does not constitute investment advice. All forward-looking statements are subject to risks and uncertainties, and actual results may differ materially from those projected. Investors should review McCormick & Company’s full SEC filings and consult their own financial advisors before making investment decisions.

View MCCORMICK & CO INC Historical chart here



IonQ, Inc. Files 8-K With SEC Detailing Corporate Information and Legal Opinion – February 27, 2026

IonQ, Inc. Files Prospectus Supplement for Resale of 5.1 Mil...

Cardiff Oncology Reports Positive Phase 2 Results for Onvansertib in RAS-Mutated mCRC and Provides 2025 Financial Update

Cardiff Oncology Reports Full Year 2025 Results & Business U...

   Ad